Detalles de la búsqueda
1.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol;
98(4): 645-657, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606708
2.
Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis.
Eur Respir J;
55(6)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079644
3.
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.
JCO Precis Oncol;
8: e2300631, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38815178
4.
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.
Eur J Cancer;
205: 114075, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733717
5.
Antibody drug conjugates in older patients: State of the art.
Crit Rev Oncol Hematol;
193: 104212, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007063
6.
Immunosenescence, inflammaging, and cancer immunotherapy efficacy.
Expert Rev Anticancer Ther;
22(9): 915-926, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815381
7.
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
Eur J Cancer;
158: 217-224, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34627664
Resultados
1 -
7
de 7
1
Próxima >
>>